- Home
- HCA vs BUD Comparison
HCA vs BUD Comparison
Compare HCA & BUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCA | BUD |
|---|---|---|
| Founded | 1968 | 1366 |
| Country | United States | Belgium |
| Employees | 316000 | N/A |
| Industry | Hospital/Nursing Management | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.3B | 123.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HCA | BUD |
|---|---|---|
| Price | $481.77 | $68.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 1 |
| Target Price | ★ $472.12 | $88.00 |
| AVG Volume (30 Days) | 1.0M | ★ 1.8M |
| Earning Date | 01-27-2026 | 02-25-2026 |
| Dividend Yield | 0.60% | ★ 1.41% |
| EPS Growth | ★ 15.74 | N/A |
| EPS | ★ 25.82 | 3.00 |
| Revenue | ★ $74,372,000,000.00 | $58,605,000,000.00 |
| Revenue This Year | $8.35 | $0.67 |
| Revenue Next Year | $4.47 | $5.43 |
| P/E Ratio | ★ $18.54 | $22.00 |
| Revenue Growth | ★ 6.82 | N/A |
| 52 Week Low | $295.00 | $46.30 |
| 52 Week High | $520.00 | $72.13 |
Technical Indicators
Market Signals| Indicator | HCA | BUD |
|---|---|---|
| Relative Strength Index (RSI) | 54.53 | 73.56 |
| Support Level | $466.01 | $63.14 |
| Resistance Level | $483.98 | $65.99 |
| Average True Range (ATR) | 10.01 | 0.85 |
| MACD | 0.81 | 0.48 |
| Stochastic Oscillator | 75.85 | 94.65 |
Price Performance
Historical ComparisonAbout HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
About BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 it acquired SABMiller.